Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongfeng Qu

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Stem Cells (Dayton, Ohio)|October 15, 2013
Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injuryRandal May, Dongfeng Qu, Nathaniel Weygant, et al.
Cancer Letters|October 14, 2023
Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancerSamrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Journal of Nanobiotechnology|September 21, 2011
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanismSripathi M Sureban, Randal May, Fadee G Mondalek, et al.
Cell Death and Differentiation|November 28, 2018
Dclk1 in tuft cells promotes inflammation-driven epithelial restitution and mitigates chronic colitisJun Yi, Kirk Bergstrom, Jianxin Fu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2026
DCLK1 regulates stemness and IL-6/STAT3-dependent metastatic niche formation in chemoresistant ovarian cancerSamrita Dogra, Sugantha Priya Elayapillai, Cole Hladik, et al.
Cancer Letters|July 3, 2025
Corrigendum to "Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer" [Cancer Lett. 2023 Dec 1;578:216437]Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Plos One|August 19, 2015
Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced ColitisDongfeng Qu, Nathaniel Weygant, Randal May, et al.
Molecular Cancer|June 3, 2014
Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1Nathaniel Weygant, Dongfeng Qu, William L Berry, et al.
Oncotarget|September 12, 2014
DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transitionParthasarathy Chandrakesan, Nathaniel Weygant, Randal May, et al.
International Journal of Molecular Sciences|November 11, 2022
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling AxisLing Ding, Yuning Yang, Qin Lu, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Stem Cells (Dayton, Ohio)|October 15, 2013
Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injuryRandal May, Dongfeng Qu, Nathaniel Weygant, et al.
Cancer Letters|October 14, 2023
Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancerSamrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Journal of Nanobiotechnology|September 21, 2011
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanismSripathi M Sureban, Randal May, Fadee G Mondalek, et al.
Cell Death and Differentiation|November 28, 2018
Dclk1 in tuft cells promotes inflammation-driven epithelial restitution and mitigates chronic colitisJun Yi, Kirk Bergstrom, Jianxin Fu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2026
DCLK1 regulates stemness and IL-6/STAT3-dependent metastatic niche formation in chemoresistant ovarian cancerSamrita Dogra, Sugantha Priya Elayapillai, Cole Hladik, et al.
Cancer Letters|July 3, 2025
Corrigendum to "Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer" [Cancer Lett. 2023 Dec 1;578:216437]Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Plos One|August 19, 2015
Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced ColitisDongfeng Qu, Nathaniel Weygant, Randal May, et al.
Molecular Cancer|June 3, 2014
Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1Nathaniel Weygant, Dongfeng Qu, William L Berry, et al.
Oncotarget|September 12, 2014
DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transitionParthasarathy Chandrakesan, Nathaniel Weygant, Randal May, et al.
International Journal of Molecular Sciences|November 11, 2022
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling AxisLing Ding, Yuning Yang, Qin Lu, et al.
Pageof 5